Warby Parker (WRBY) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Warby Parker

NYSE•Healthcare•Medical Instruments & Supplies

$23.55-0.79(-0.03%)Pre-market

Market Cap

$3.00B

P/E

387.1x

P/S

3.3x

P/B

7.6x

Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses. It also provides accessories, such as cases, pouches, lenses kit with anti-fog spray, travel cases, lenses cloth, anti-fog lens spray, and sun clip-ons through its stores, website, and mobile apps. In addition, the company offers eye exams and vision tests, as well as optical services. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

How this company scores

AverageMetricSide Score: 56/100

Strongest: Growth (21/25); weakest: Cash & Earnings Quality (7/25).

Profitability13/25

Growth21/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality7/25

Strengths

Rising earningsInterest easily coveredProfit converts from growthConsistent growth

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 387.1x5y range 387.1x – 4747.0x

Currently below its 4-quarter median.

P/S · 3.3x5y range 1.6x – 4.0x

Currently near its 17-quarter median.

P/B · 7.6x5y range 4.1x – 14.6x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg -1.4x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $3.00B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $911.61M
Q. Revenue: $235.51M
TTM EBITDA: $55.02M
TTM Op. Income: $1.55M
Q. Op. Income: $3.17M
TTM Net Income: $7.74M
Q. Net Income: $4.64M
EPS: $0.04
Shares Out.: $123.94M

$911.61M in TTM revenue grew 11.0% YoY, reaching $235.51M last quarter. TTM EBITDA of $55.02M and TTM operating income of $1.55M show growth is flowing through to the bottom line. TTM net income of $7.74M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 57.9%
EBITDA Margin: 7.3%
Op. Margin: 1.3%
Net Margin: 2.0%

Op. margin of 1.3% is up 3.5% YoY — cost efficiency is improving. Net margin at 2.0% and gross margin of 57.9% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 387.1x
P/S Ratio: 3.3x
P/B Ratio: 7.6x

At 387.1x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 3.3x and P/B of 7.6x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 0% — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $772.32M
Cash: $292.67M
Long-Term Debt: N/A
Book Value: $391.99M
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $29.62M
TTM Free Cash Flow: $21.75M
FCF Margin: 2.4%
FCF / Net Income: 2.8

TTM FCF of $21.75M on $29.62M in operating cash flow. The FCF / Net Income ratio of 2.8x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has fallen for 2 consecutive quarters — a weakening trend.